Chronic Disease Medicines & Devices

Own the medicines and medical devices used to manage persistent metabolic, cardiovascular and immune disorders, where ongoing treatment supports recurring demand. The basket offers an alternative to AI infrastructure exposure, with its liquid core drawn from drugmakers and Medtronic and complemented by diabetes specialists. Recent healthcare strength supports the timing, but reimbursement pressure, clinical setbacks and elevated expectations remain meaningful risks. Launch basket (equal weight): LLY, ABBV, AMGN, JNJ, MDT, NVO, ABT, DXCM Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.